Epigenetic Aspects of the Noncoding Genome and the Epithelial–Mesenchymal Transition

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".

Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 498

Special Issue Editors


E-Mail Website
Guest Editor
Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Roma, Italy
Interests: epigenetics; long noncoding RNAs; extracellular vesicles; cancer; cell differentiation; chromatin

E-Mail Website
Guest Editor
Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Roma, Italy
Interests: epigenetics; long noncoding RNAs; extracellular vesicles; cancer; infectious diseases; liver

Special Issue Information

Dear Colleagues,

The aim of this Special Issue is to focus on the role of transcription factors, epigenetic modifications, chromatin remodeling, and noncoding RNAs in the dynamic event referred to as the epithelial to mesenchymal transition (EMT). During physiological and pathological EMT, cells undergo a profound reprogramming, implying regulation of the expression of numerous genes. In this scenario, a crucial role is performed by transcription factors in driving or inhibiting EMT (e.g., SNAIL) as well as by histone modifications, chromatin architecture and, more recently characterized, noncoding RNAs, in particular microRNAs and lncRNAs. Since this dynamic situation allows for the progression of the complex EMT transdifferentiation program, new insights into the characterization of molecular players involved in this process represent a fundamental field of interest for driving future research. Comprehensive reviews and original articles covering this theme are both welcome in this Special Issue.

Dr. Cecilia Battistelli
Prof. Marco Tripodi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • EMT
  • lncRNAs
  • microRNAs
  • chromatin
  • tumor
  • fibrosis
  • histones
  • transcription regulation
  • gene expression
  • transcriptional factors

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop